Results 111 to 120 of about 1,393 (127)

Sapropterin

Drugs, 2012
Mark Sanford, Sanford Mark
exaly  

Relative bioavailability of sapropterin from intact and dissolved sapropterin dihydrochloride tablets and the effects of food: A randomized, open-label, crossover study in healthy adults

Clinical Therapeutics, 2010
Donald G Musson
exaly  

A randomized, placebo-controlled, double-blind study of sapropterin to treat ADHD symptoms and executive function impairment in children and adults with sapropterin-responsive phenylketonuria

Molecular Genetics and Metabolism, 2015
A Feigenbaum
exaly  

Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study

Lancet, The, 2007
Anupam Chakrapani, Maureen Cleary, François Feillet   +2 more
exaly  

Introduction of sapropterin dihydrochloride as standard of care in patients with phenylketonuria

Molecular Genetics and Metabolism, 2010
Hilary J Vernon, M R Johnson, A Bergner   +2 more
exaly  

Use of sapropterin in the management of phenylketonuria: Seven case reports

Molecular Genetics and Metabolism, 2013
H Gökmen Ozel, A M Lammardo, Julio Cesar Rocha   +2 more
exaly  

Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study

Translational Psychiatry, 2013
Richard E Frye, Frye R E, Slattery J
exaly  

Evolving patient selection and clinical benefit criteria for sapropterin dihydrochloride (Kuvan®) treatment of PKU patients

Molecular Genetics and Metabolism, 2012
Patricia Gordon, Janet A Thomas, Elaina Jurecki   +2 more
exaly  

Safety and efficacy of 22 weeks of treatment with sapropterin dihydrochloride in patients with phenylketonuria

American Journal of Medical Genetics, Part A, 2008
Jon Wolff, Udo Wendel, Marcello Giovannini   +2 more
exaly  

Efficacy and safety of sapropterin dihydrochloride in patients with phenylketonuria: A meta‐analysis of randomized controlled trials

British Journal of Clinical Pharmacology, 2019
Jinghan Qu, Lingyun Ma, Ying Zhou
exaly